undamentalytics Newsletter
Sign in

908 Devices Inc. income statement

In fiscal 2025, 908 Devices Inc. reported revenue of $56.2m, up 17.7% on the year before, operating income of −$39.4m (a -70.1% margin) and net income of $19.5m, or $0.54 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue27424750485661
Cost of revenue12192125232829
Gross profit15232625252832
Research and development8131822151614
Selling, general and administrative13324446393939
Operating income−6−22−35−43−57−39−39
Interest expense1000———
Income before tax——−34−37−53−33—
Income tax——0−0−0−0—
Net income−13−22−34−36−7219−35
Diluted EPS−$0.47−$0.79−$1.07−$1.13−$2.12$0.54−$0.94
Diluted shares (average)27m28m31m32m34m36m37m
EBITDA−5−21−34−40−53−35−35

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: MASS vs PRPOCSBR vs MASSMASS vs PSNL

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from 908 Devices Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to 908 Devices Inc.